SYNTHETIC Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Synthetic, and what generic alternatives are available?
Synthetic is a drug marketed by Teva Womens and is included in one NDA.
The generic ingredient in SYNTHETIC is estrogens, conjugated synthetic a. There are three drug master file entries for this compound. Additional details are available on the estrogens, conjugated synthetic a profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for SYNTHETIC?
- What are the global sales for SYNTHETIC?
- What is Average Wholesale Price for SYNTHETIC?
Summary for SYNTHETIC
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | SYNTHETIC at DailyMed |
US Patents and Regulatory Information for SYNTHETIC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Womens | SYNTHETIC CONJUGATED ESTROGENS A | estrogens, conjugated synthetic a | CREAM;VAGINAL | 021788-001 | Nov 28, 2008 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
